SYK
55
7
V
58
2
MTB
50
-5
PEP
35
2
TSN
34
-2
ES
41
2
PH
60
-4
ROP
68
3
NEM
57
2
EIX
61
5
ILMN
42
5
MNST
71
15
DUK
50
3
WM
76
2
SE
58
11
SJM
38
2
FITB
53
-5
ACN
43
-6
VRSK
80
3
COP
50
-4
SYK
55
7
V
58
2
MTB
50
-5
PEP
35
2
TSN
34
-2
ES
41
2
PH
60
-4
ROP
68
3
NEM
57
2
EIX
61
5
ILMN
42
5
MNST
71
15
DUK
50
3
WM
76
2
SE
58
11
SJM
38
2
FITB
53
-5
ACN
43
-6
VRSK
80
3
COP
50
-4
Financhill
Back

Aldeyra Therapeutics 10K Form

Sell
34

ALDX
Aldeyra Therapeutics

Last Price:
3.18
Seasonality Move:
16.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALDX News And Ratings

See the #1 stock for the next 7 days that we like better than ALDX

ALDX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-9.97M
Price / Cash Flow: 0
Annual Sales: $1.91
Price / Book: 1.67

Profitability

EPS (TTM): -0.51000
Net Income (TTM): $-30.01M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Aldeyra Therapeutics Earnings Forecast

Key Aldeyra Therapeutics Financial Ratios

  • The Interest Expense is -5.52% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 8 years.

Aldeyra Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALDX
CUSIP: 01438T
Website: aldeyra.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALDX Technical Analysis vs Fundamental Analysis

Sell
34
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy or a Sell?